Association of follow-up neutrophil-lymphocyte ratio with postoperative pneumonia in aneurysmal subarachnoid hemorrhage patients after endovascular treatment: a retrospective analysis

动脉瘤性蛛网膜下腔出血患者血管内治疗后随访中性粒细胞-淋巴细胞比值与术后肺炎的相关性:一项回顾性分析

阅读:1

Abstract

INTRODUCTION: Research on the relationship between dynamic neutrophil-to-lymphocyte ratio (NLR)-measured at different time points around endovascular treatment-and the occurrence of postoperative pneumonia (POP) in patients with aneurysmal subarachnoid hemorrhage (aSAH) is still relatively scarce. This study aims to explore the association between dynamic NLR and the incidence of POP in patients with aSAH undergoing endovascular therapy. METHODS: This study included patients with aSAH who underwent endovascular treatment between January 2019 and April 2023. The follow-up endpoint was the presence of POP at 30 days postoperatively. Logistic regression analysis was conducted using POP as the dependent variable. The NLR was calculated at admission (NLR1), 24 h after endovascular treatment (NLR2), and 3-7 days after endovascular treatment (NLR3). Four prediction models were constructed: Model 1 (variables with p < 0.05, except for the NLR), Model 2 (Model 1 plus NLR1), Model 3 (Model 1 plus NLR2), and Model 4 (Model 1 plus NLR3). RESULTS: Among the 154 patients with aSAH, POP occurred in 101 (65.6%) patients. Higher NLRs at admission [odds ratio (OR) = 1.08; 95% confidence interval (CI): 1.02, 1.16; p = 0.019], 24 h postoperatively (OR = 1.14; 95% CI = 1.05, 1.25; p = 0.005) and 3-7 days postoperatively (OR = 1.17; 95% CI = 1.02, 1.38; p = 0.04) were associated with the occurrence of POP. CONCLUSION: Follow-up NLR may be associated with POP in patients with aSAH treated endovascularly. Elevated NLR at admission, 24 h postoperatively, and 3-7 days postoperatively correlated with a high risk for POP.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。